JN, R., V, P., M, K., K, S., D, E., H, Y., . . . GJ, N. (2022). Immunogenicity and protective efficacy of RSV G central conserved domain vaccine with a prefusion nanoparticle. NPJ vaccines, 7(1), 74. https://doi.org/10.1038/s41541-022-00487-9
Chicago Style (17th ed.) CitationJN, Rainho-Tomko, et al. "Immunogenicity and Protective Efficacy of RSV G Central Conserved Domain Vaccine with a Prefusion Nanoparticle." NPJ Vaccines 7, no. 1 (2022): 74. https://doi.org/10.1038/s41541-022-00487-9.
MLA (9th ed.) CitationJN, Rainho-Tomko, et al. "Immunogenicity and Protective Efficacy of RSV G Central Conserved Domain Vaccine with a Prefusion Nanoparticle." NPJ Vaccines, vol. 7, no. 1, 2022, p. 74, https://doi.org/10.1038/s41541-022-00487-9.
Warning: These citations may not always be 100% accurate.